Related Experiment Video
Updated: Jun 12, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.5K
Significant Published Articles in 2024 for Pharmacy Nutrition Support Practice
Roland N Dickerson1, Titilola M Afolabi1, Angela L Bingham2
1University of Tennessee Health Science Center, Memphis, TN, USA.
Hospital Pharmacy
|May 23, 2025
Summary
Pharmacists can stay updated on nutrition support therapy with key 2024 literature. This review highlights 7 high-impact primary articles and 12 guidelines crucial for pharmacy practice.
Area of Science:
- Clinical Pharmacy
- Nutritional Science
- Evidence-Based Practice
Background:
- Keeping abreast of the latest research is vital for pharmacists in nutrition support.
- The rapid expansion of scientific literature necessitates curated reviews.
Purpose of the Study:
- To identify and summarize high-impact articles for pharmacists involved in nutrition support therapy.
- To provide a concise overview of essential literature published in 2024 relevant to pharmacy nutrition support.
Main Methods:
- A panel of board-certified nutrition support pharmacists identified and ranked relevant 2024 publications.
- Articles were selected if deemed important by at least 5 out of 8 participating pharmacists.
- Key guidelines and consensus papers were also included.
Main Results:
- 160 articles were initially identified, with 7 primary literature articles rated as highly important.
- 12 significant guideline, position, recommendation, or consensus papers were also identified.
- Summaries and practice implications for the top-ranked articles were provided.
Conclusions:
- Pharmacists engaged in nutrition support therapy should familiarize themselves with these critical 2024 publications.
- The identified literature offers valuable insights for contemporary pharmacy nutrition support practice.
Related Concept Videos
01:26Enteral Nutrition I: Orogastric and Nasogastric Feeding
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).